These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8551113)

  • 21. No effects of extremely low frequency magnetic fields found on cytotoxic activities and cytokine production of human peripheral blood mononuclear cells in vitro.
    Ikeda K; Shinmura Y; Mizoe H; Yoshizawa H; Yoshida A; Kanao S; Sumitani H; Hasebe S; Motomura T; Yamakawa T; Mizuno F; Otaka Y; Hirose H
    Bioelectromagnetics; 2003 Jan; 24(1):21-31. PubMed ID: 12483662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Super-sensitive epithelial cell line and colorimetric assay to replace the conventional K562 target and chromium release assay for assessment of non-MHC-restricted cytotoxicity.
    Nouri AM; Mansouri M; Hussain RF; Dos Santos AV; Oliver RT
    J Immunol Methods; 1995 Mar; 180(1):63-8. PubMed ID: 7534804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isolation and characterization of cytotoxic granules from human lymphokine (interleukin 2) activated killer cells.
    Lowrey DM; Hameed A; Lichtenheld M; Podack ER
    Cancer Res; 1988 Aug; 48(16):4681-8. PubMed ID: 3260817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of 2.35-T MR imaging on natural killer cell cytotoxicity with and without interleukin-2.
    Prasad N; Lotzová E; Thornby JI; Taber KH
    Radiology; 1990 Apr; 175(1):261-3. PubMed ID: 2315491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The effect of tumor-dendritic cell fusion vaccines on the cytotoxicity of CIK/NK cells from cord blood].
    Li Y; Huang SL; Wu YF; Wei J; Meng Y; Zhou DH; Bao R
    Zhonghua Xue Ye Xue Za Zhi; 2005 May; 26(5):269-72. PubMed ID: 15949286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of postbinding target cell lysis and of lymphokine-induced enhancement of human natural killer cell activity by in vitro exposure to ultraviolet B radiation.
    Elmets CA; Larson K; Urda GA; Schacter B
    Cell Immunol; 1987 Jan; 104(1):47-58. PubMed ID: 3802213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interferon-Beta combined with interleukin-2 restores human natural cytotoxicity impaired in vitro by ionizing radiations.
    Franzese O; Tricarico M; Starace G; Pepponi R; Bonmassar L; Cottarelli A; Fuggetta MP
    J Interferon Cytokine Res; 2013 Jun; 33(6):308-18. PubMed ID: 23421371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased natural killer (NK) susceptibility of human NK target cells after phosphatidylinositol-specific phospholipase C treatment.
    Uggla C; Une C; Axberg I; Jondal M; Knowles RW; Orn A
    Scand J Immunol; 1989 Jan; 29(1):83-9. PubMed ID: 2537997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Natural killer cell immunodeficiency in patients with chronic myelogenous leukemia. IV. Interleukin-1 deficiency, gamma-interferon deficiency and the restorative effects of short-term culture in the presence of interleukin-2 on natural killer cytotoxicity, natural killer-target binding and production of natural killer cytotoxic factor.
    Chang WC; Hsiao MH; Pattengale PK
    Nat Immun Cell Growth Regul; 1991; 10(2):57-70. PubMed ID: 1881400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
    Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiosensitivity of NK lytic activities and NK-mediated hematopoietic colony inhibition: effect of activation with IL-2 and blocking of the T-200 molecule.
    Keever CA; Benazzi E; Kernan NA; Welte K; O'Reilly RJ; Bordignon C
    Cell Immunol; 1988 Apr; 113(1):143-57. PubMed ID: 3259165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant interferons or interleukin-2 increase cytotoxicity by human monocytes and NK cells.
    Frey JR; Kamber M; Peck R
    Lymphokine Res; 1987; 6(3):215-27. PubMed ID: 3114569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro cytotoxicity and transplantation protection by autologous natural and activated killer cells against an in vitro transformed tumorigenic fibroblast line. A case study.
    Wilhelm SA; Mukherji B
    J Clin Invest; 1985 Apr; 75(4):1162-8. PubMed ID: 3988936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural killer (NK)-resistant human lung cancer cells are lysed by recombinant interleukin-2-activated NK cells.
    Robinson BW; Morstyn G
    Cell Immunol; 1987 May; 106(2):215-22. PubMed ID: 3494538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukins 2 and 12 produce recovery of cytotoxic function in tributyltin-exposed human natural killer cells.
    Whalen MM; Williams TB; Green SA; Loganathan BG
    Environ Res; 2002 Mar; 88(3):199-209. PubMed ID: 12051798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of X-ray irradiation on natural killer (NK) cell system. I. Elevation of sensitivity of tumor cells and lytic function of NK cells.
    Uchida A; Mizutani Y; Nagamuta M; Ikenaga M
    Immunopharmacol Immunotoxicol; 1989; 11(2-3):507-19. PubMed ID: 2482851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of natural killer cell-mediated cytotoxicity by tamoxifen and estradiol.
    Baral E; Nagy E; Berczi I
    Cancer; 1995 Jan; 75(2):591-9. PubMed ID: 7812928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation of nonspecific murine cytotoxic T cells in vitro by purified human interleukin 2.
    Merluzzi VJ; Savage DM; Mertelsmann R; Welte K
    Cell Immunol; 1984 Mar; 84(1):74-84. PubMed ID: 6199125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endogenous IL-2 production by natural killer cells maintains cytotoxic and proliferative capacity following retroviral-mediated gene transfer.
    Miller JS; Tessmer-Tuck J; Blake N; Lund J; Scott A; Blazar BR; Orchard PJ
    Exp Hematol; 1997 Oct; 25(11):1140-8. PubMed ID: 9328450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ewing's sarcoma: ex vivo sensitivity towards natural and lymphokine-activated killing.
    Atzpodien J; Gulati SC; Shimazaki C; Bührer C; Oz S; Kwon JH; Kolitz JE; Clarkson BD
    Oncology; 1988; 45(6):437-43. PubMed ID: 3263598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.